Clinical Trials State of the Industry Report 2005: Market Forces Drive Change in Drug Development, Released by BioWorld Today

Applied Clinical Trials

Thomson BioWorld has just published Clinical Trials State Of The IndustryReport 2005, a new report focusing on the clinical research industry.

ATLANTA GA USA -- MEDICAL INDUSTRY E-MAIL NEWS SERVICE(TM) -- MAY 18 2005 --Thomson BioWorld has just published Clinical Trials State Of The IndustryReport 2005, a new report focusing on the clinical research industry.

With content researched and collected by Thomson CenterWatch, the leading information provider for the clinical trials industry, this market research report reveals critical data and information about trends affecting the drug development and study conduct markets, both in the US and Europe.


-- Drug development spending and cycle times
-- Pharmaceutical spending
-- Clinical grants spending
-- Clinical research spending - US and worldwide
-- CRO market size, costs and performance
-- Study conduct/clinical trials markets
-- Investigative sites

The Clinical Trials State Of The Industry Report 2005 gives detailed insight into the trends and history affecting the clinical research industry. It contains more than 300 up-to-date charts and graphs, special "Year in Review" sections for 2003 and 2004, and noteworthy articles relating to:

-- Phase I spending
-- The top CROs in Europe
-- Expanding opportunities in Central and Eastern Europe
-- Physicians referring patients into clinical trials
-- CRC loss tied to heavy workload
-- And much more.

"By combining more than 300 tables and charts with expert opinions from industry thought-leaders, the Clinical Trials State of the Industry Report 2005 is an ideal resource for creating dynamic data-driven presentations, preparing business plans and marketing strategies, and deepening your understanding of the clinical trials sector," says Managing Editor Michael Harris. "If you're a biotech or pharmaceutical executive, researcher, analyst or investor with a stake in the clinical research industry, this report is for you."


To view sample pages or order the Clinical Trials State Of The Industry Report 2005: Market Forces Drive Change In Drug Development, please visit:

The Thomson Corporation, with 2004 revenues of $8.10 billion, is a global leader in providing integrated information solutions to business and professional customers.

Thomson provides value-added information, software tools, and applications to more than 20 million users in the fields of scientific research, healthcare, law, tax, accounting, financial services, higher education, reference information, and corporate e-learning and assessment. With operational headquarters in Stamford CT, Thomson has approximately 38,000 employees and provides services in approximately 130 countries. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson BioWorld (a Thomson business) information solutions can be found at: an internationally recognized site for executives, analysts and investors following the day-to-day developments in the biotechnology, pharmaceutical and med-tech markets. Focusing on scientific business news and information, Thomson BioWorld's data-rich website provides access to daily developments in these sectors, as well as 15 years' worth of archived data, trends and company information. Key products include BioWorld Today - the newspaper of record for the biotechnology industry; BioWorld Financial Watch - a weekly monitor of biotech's financial markets; and BioWorld International - focusing on life science developments in Europe.

Thomson CenterWatch (a Thomson Business) is a leader in the clinical trials industry. With a specific focus on the clinical trials industry, CenterWatch is a Boston-based publishing and information services company that provides business journalism, reference databases, accredited training manuals, original research and analysis, and market intelligence services to assist organizations in managing and implementing clinical research strategies and operational initiatives.